Pediatrix Medical Group, Inc. (MD) Stock Overview
Explore Pediatrix Medical Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pediatrix Medical Group, Inc. (MD)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
12.51
EPS (TTM)
$2.24
ROE
0.20%
MD Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Pediatrix Medical Group, Inc. (NYSE: MD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Pediatrix Medical Group, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MD on the NYSE shows an RSI of 51.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $29.63 for the NYSE listing.
Key metrics behind Pediatrix Medical Group, Inc.'s NYSE-traded stock include a P/E ratio of 12.51 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MD on the NYSE.